Needle core biopsies

DIAGNOSTIC_TEST2 trials

Sponsors

Jewish General Hospital, Sunnybrook Health Sciences Centre

Conditions

Breast CancerBreast NeoplasmsCancer, BreastMetastatic Breast CancerTriple Negative Breast Cancer

Unknown Phase

Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

CompletedNCT01276899

Jewish General HospitalTriple Negative Breast Cancer

Start: 2010-09-30Target: 80Updated: 2022-06-02

Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients

RecruitingNCT04608357

Sunnybrook Health Sciences CentreBreast Cancer, Breast Neoplasms, Cancer, Breast +1

Start: 2021-07-21End: 2027-12-31Target: 25Updated: 2025-01-20

Related Papers

Cancer cell extravasation requires <sup>i</sup>plectin-mediated delivery of MT1-MMP at invadopodia.

2024-07-054 citations

Circulating tumor DNA (ctDNA) during and after neoadjuvant chemotherapy and prior to surgery is a powerful prognostic factor in triple-negative breast cancer (TNBC).

Journal of Clinical Oncology2019-05-208 citations

Abstract P2-02-02: Dynamics of ctDNA changes during neoadjuvant chemotherapy in triple-negative breast cancer patients

Cancer Research2018-02-15

Abstract P6-03-03: The Q-CROC-3 project reveals novel genomic alterations in triple negative breast cancers in residual tumors after neoadjuvant chemotherapy

Cancer Research2016-02-15